Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection.

MLA

Li, Ya-Nan, et al. “Inhibition of Myeloid-Derived Suppressor Cell Arginase-1 Production Enhances T-Cell-Based Immunotherapy against Cryptococcus Neoformans Infection.” Nature Communications, vol. 13, no. 1, July 2022, p. 4074. EBSCOhost, https://doi.org/10.1038/s41467-022-31723-4.

APA

Li, Y.-N., Wang, Z.-W., Li, F., Zhou, L.-H., Jiang, Y.-S., Yu, Y., Ma, H.-H., Zhu, L.-P., Qu, J.-M., & Jia, X.-M. (2022). Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection. Nature Communications, 13(1), 4074. https://doi.org/10.1038/s41467-022-31723-4

Chicago

Li, Ya-Nan, Zhong-Wei Wang, Fan Li, Ling-Hong Zhou, Yan-Shan Jiang, Yao Yu, Hui-Hui Ma, Li-Ping Zhu, Jie-Ming Qu, and Xin-Ming Jia. 2022. “Inhibition of Myeloid-Derived Suppressor Cell Arginase-1 Production Enhances T-Cell-Based Immunotherapy against Cryptococcus Neoformans Infection.” Nature Communications 13 (1): 4074. doi:10.1038/s41467-022-31723-4.